Stock Options (Tables)

12 Months Ended

Dec. 31, 2012


	2012				2011				2010
				Weighted				Weighted				Weighted
				Average				Average				Average
				Exercise				Exercise				Exercise
	Shares			Price	Shares			Price	Shares			Price
Outstanding,
beginning of year	1,471,000		$	0.61	1,571,000		$	0.60	3,021,000		$	0.42
Granted	87,500		$	0.85	186,745		$	1.01	396,000		$	0.44
Exercised	(105,000	)	$	0.50	(50,000	)	$	0.57	(1,831,000	)	$	0.27
Expired/cancelled	(81,250	)	$	1.12	(236,745	)	$	0.82	(15,000	)	$	0.58
Outstanding, end of
year	1,372,250		$	0.61	1,471,000		$	0.61	1,571,000		$	0.60
Exercisable, end of
year	1,212,250		$	0.62	1,231,000		$	0.63	795,000		$	0.70

Schedule Of Stock Options Outstanding And Exercisable


	Weighted Average	Options Outstanding	Weighted Average	Options
	Exercise Price	(shares)	Remaining Contractual	Exercisable
			Life (years)	(shares)
$	0.57	400,000	0.1	400,000
$	1.44	50,000	0.4	50,000
$	0.70	50,000	1.0	50,000
$	0.50	400,000	2.8	240,000
$	0.43	50,000	2.1	50,000
$	0.44	241,000	2.7	241,000
$	1.08	50,000	3.3	50,000
$	1.16	18,750	3.3	18,750
$	0.84	18,750	3.5	18,750
$	0.72	18,750	3.8	18,750
$	0.75	18,750	4.0	18,750
$	1.07	18,750	4.2	18,750
$	0.81	18,750	4.5	18,750
$	0.73	18,750	4.7	18,750

		1,372,250		1,212,250

Schedule Of Options Issued


Options Issued to	Total Options Issued to
Each Non-executive	Non-executive Directors		Exercise Price	Grant Date	Expiration Date
Director
6,250	25,000	$	0.75	1/3/2012	1/2/2017
6,250	25,000	$	1.07	4/2/2012	4/1/2017
6,250	18,750	$	0.81	7/2/2012	7/1/2017
6,250	18,750	$	0.73	10/1/2012	9/30/2017

- Definition

Tabular disclosure of components of a stock option or other award plan under which equity-based compensation is awarded to employees, typically comprised of the amount of unearned compensation (deferred compensation cost), compensation expense, and changes in the quantity and fair value of the shares (or other type of equity) granted, exercised, forfeited, and issued and outstanding pertaining to that plan. Disclosure may also include nature and general terms of such arrangements that existed during the period and potential effects of those arrangements on shareholders, effect of compensation cost arising from equity-based payment arrangements on the income statement, method of estimating the fair value of the goods or services received, or the fair value of the equity instruments granted, during the period, cash flow effects resulting from equity-based payment arrangements and, for registrants that accelerate vesting of out of the money share options, reasons for the decision to accelerate.

+ References+ Details